BioPharma Clinical Trials
Huadong Medicine Announces Positive Phase I Clinical Trial Results for Oral GLP-1 Receptor Agonist HDM1002 in China
HUADONG MEDICINE, through its wholly-owned subsidiary Hangzhou Zhongmei HuaDong Pharmaceutical CO. LTD (Zhongmei HuaDong), has recently announced positive ...
June 27, 2024 | News
South Korea Approves Reimbursement for Antengene's XPOVIO®, Expanding Access to Relapsed/Refractory Multiple Myeloma Treatment
- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treat...
June 27, 2024 | News
Merck Halts Phase III TrilynX Study for Xevinapant in Head and Neck Cancer Following Interim Analysis
Merck, a leading science and technology company, announced the discontinuation of the Phase III randomized TrilynX study evaluating xevinapant plus chemora...
June 25, 2024 | News
FDA Approves iRegene's NouvNeu001, Marking Milestone in Parkinson's Disease Treatment
U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's...
June 25, 2024 | News
EU Approves HUTCHMED's FRUZAQLA® for Previously Treated Metastatic Colorectal Cancer
— Approval for previously treated metastatic colorectal cancer based on results from positive, global, Phase III FRESCO-2 Trial — — FRUZ...
June 24, 2024 | News
Novo Nordisk's FRONTIER2 Trial: Up to 95% of cPatients Achieve Zero Bleeds on Mim8
FRONTIER2 data presented at ISTH 2024 showed that up to 95% of people, who had no prior prophylaxis treatment, experienced zero treated bleeds while on Mim...
June 24, 2024 | News
Gilead Sciences Announces 100% Efficacy in Phase 3 PURPOSE 1 Trial for HIV Prevention in Cisgender Women
Gilead Sciences, Inc. announced topline results from an interim analysis of its pivotal Phase 3 PURPOSE 1 trial, demonstrating that the company’s twi...
June 21, 2024 | News
Enveda Biosciences Secures $55 Million in Latest Financing Round
Enveda Biosciences a biotechnology company using AI to translate nature into new medicines, announced today a new financing round of $55 million to add to ...
June 17, 2024 | News
SciRhom GmbH Secures Approval for Clinical Trial Application of SR-878 in Austria
SciRhom GmbH, a biopharmaceutical company pioneering the development of first-in-class therapeutic antibodies, announced the approval of a clinical trial a...
June 14, 2024 | News
IQVIA Launches One Home for Sites™ to Streamline Clinical Trial Management
IQVIA announced the launch of One Home for Sites™, a new technology platform that acts as a single sign-on and a single dashboard for the key systems...
June 13, 2024 | News
GC Biopharma and Novel Pharma Receive FDA Fast Track Designation for Sanfilippo Syndrome Treatment GC1130A
GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has granted Fast Track Designation for their jointly developed MPSIIIA (Sanfili...
June 11, 2024 | News
DeepQure Initiates Early Feasibility Study for Groundbreaking HyperQure™ System Following FDA Approval
DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic approach) solution for renal denervation (RDN), announce...
June 11, 2024 | News
Vertex's TRIKAFTA® Shows Significant Clinical Benefits in Cystic Fibrosis Patients with Rare Mutations
Results from a randomized, placebo-controlled study of TRIKAFTA® in people with cystic fibrosis with rare, non-F508del CFTR mutations s...
June 10, 2024 | News
MLB Receives FDA Approval for TML-6 IND Application to Treat Alzheimer's Disease
MLB (Merry Life Biomedical Company, Ltd., Taiwan ) a biomedical company, announced that the U.S. Food and Drug Administration (FDA) h...
June 07, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
